Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or New Hampshire for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to New Hampshire only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. New Hampshire (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Daniel Peraza (NPI 1073635355)

Field	Value
Entity Type	Individual
Organization	Daniel Peraza
Address	252 Broad St
City	Claremont
State	NH
ZIP	03743
Taxonomy	Dermatology Physician
NPI Enumerated	April 6, 2007

Payer Source	Total Paid
Medicare	$1.1M
Medicaid	$0

Key Findings

DANIEL PERAZA (Claremont, NH), a Dermatology Physician whose NPI was enumerated 2007-04-06 (~19 years ago), reports $1.1M in lifetime Medicare revenue and has no Medicaid billing on file, making this effectively a Medicare‑centric billing profile. The long tenure (NPI enumerated ~19 years ago) indicates an established practice footprint in the market, but the absence of Medicaid activity means payer diversification is minimal.

Revenue is highly concentrated: the precomputed top‑3 Medicare codes account for 61.9% of this provider's total Medicare revenue, with J3245 alone contributing $414.2K (39.0% of Medicare revenue). This concentration indicates that a single biologic therapy (J3245) is the dominant revenue driver, and fluctuations in access, pricing, or utilization of that drug would materially affect total Medicare revenue.

The code mix points to a hybrid ambulatory medical‑and‑procedural dermatology practice: high volumes of evaluation & management visits (99213 and 99214) alongside lesion destruction and biopsy codes (17000, 11102, 17003, 17110). 99213 generates $162.7K (15.3% of Medicare revenue) and 99214 generates $80.7K (7.6%), suggesting the practice combines routine follow‑up and problem‑focused visits with substantial in‑office procedures.

Several codes show very high national standing for volume: 99213 is labeled an "extreme outlier" (100th percentile, ranks #361 of 457151 providers) and 99214 is "notably above typical" (97th percentile). Those E/M outlier labels indicate this provider sees established patients at far higher volumes than typical peers nationally, which aligns with a high‑throughput outpatient dermatology clinic.

Procedural dermatology is also an outlier area: 17000 is an "extreme outlier" (99th percentile) with $68K revenue, 11102 is an "extreme outlier" (98th percentile) with $59.1K revenue, and the add‑on 17003 is "notably above typical" (99th percentile) with $26.1K. These labels and dollar amounts together describe unusually high rates of lesion destruction and biopsy relative to national peers, consistent with a practice that treats a large volume of premalignant/malignant skin lesions.

J3245 (tildrakizumab) is large in dollar terms but only average in national rank: it contributes $414.2K and is ranked #107 of 225 providers nationally (50th percentile, described as "typical, unremarkable volume"). This contrast — dominant revenue share from a drug that is not a national high‑volume outlier — suggests local prescribing/administration patterns (or a concentrated patient panel on biologic therapy) rather than national market leadership for that specific drug.

The profile includes multiple radiation planning/dosimetry codes (77280, 77290, 77261, 77300 and the now‑deleted 77401) with modest dollars and mostly "typical, unremarkable" percentile characterizations. Their presence at measurable but not dominant levels ($52.4K for 77280, $28.9K for 77290, $5.8K for 77300) may reflect occasional involvement with radiation planning or billing relationships with radiation services rather than a primary radiation oncology practice.

From a payer‑strategy and competitive risk perspective, the provider's reliance on Medicare ($1.1M and no Medicaid billing on file) and heavy revenue concentration in J3245 (39.0%) plus the high E/M and procedural volumes flagged as outliers create both negotiating leverage around office visit and biologic administration reimbursement and exposure to utilization shifts. For payers and analysts, this profile signals a high‑volume dermatology practice with concentrated drug revenue and above‑typical procedural throughput, warranting focused review for contract design and utilization management initiatives.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

38 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J3245	Injection, tildrakizumab, 1 mg	3,800	$110	$414.2K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	2,580	$60	$162.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	910	$90	$80.7K
17000	The provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code reports the destruction of the first or only lesion.	1,700	$40	$68K
11102	The provider biopsies a single skin lesion using a tangential (side–ways) approach; he shaves off the lesion or scoops it out with a knife or curette.	830	$70	$59.1K
77280	The provider uses a simulator or other imaging modality to determine the size and location of ports to be used for radiation therapy. This code describes a simple level service.	230	$220	$52.4K
77401	Deleted effective Jan. 1, 2026.	970	$30	$33K
99212	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a straightforward level of medical decision making,…	670	$50	$30.1K
77290	Before starting radiation therapy, a physician needs to know the location and size of the cancerous tumor, the radiation doses required to treat the tumor, and the positioning of the radiation beams…	80	$380	$28.9K
17003	In this add–on procedure, the provider destroys a premalignant lesion using techniques such as chemosurgery, cryosurgery, electrosurgery, or others. This code is appropriate for the second through…	5,230	$10	$26.1K

Showing 1–10 of 38

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 38 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. New Hampshire Distribution

Daniel Peraza — 12 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — New Hampshire

Full comparison — all codes billed, vs. state median

38 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J3245	2	10	4,000	$110	$439.2K
99214	35	3,150	110	$80	$13.2K
77401	1	10	140	$30	$12.9K
17000	1	120	190	$40	$11.4K
11102	1	100	120	$60	$9.6K
17110	38	110	110	$70	$9.4K
12032	12	40	20	$180	$7.4K
99213	1	2,900	70	$50	$6.9K
11301	5	20	40	$70	$6.5K
17004	28	50	30	$110	$6.4K

Showing 1–10 of 38

Related Providers

Other providers that share a Tax Identification Number (TIN) with Daniel Peraza, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Matthew Zipoli	MA	MOHS-Micrographic Surgery Physician	$1.1M	$0
Jose E Peraza Md PLLC	NH	Dermatology Physician	$0	$870.9K
Jose Peraza	NH	Dermatology Physician	$378.5K	$0
Jose E. Peraza	NH	Dermatology Physician	$0	$186.6K
Caleb Howard	NH	Medical Physician Assistant	$167K	$0
Ashwin Kumar	NH	Medical Physician Assistant	$166.5K	$0
Kira Schachinger	NH	Medical Physician Assistant	$86.5K	$0

Nearby Providers

Other providers in the same ZIP code as Daniel Peraza, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Developmental Services Of Sullivan County, Inc.	NH	Child Intellectual and/or Developmental Disabilities Respite Care	$0	$139.4M
Valley Regional Hospital Inc.	NH	Critical Access Hospital	$0	$10M
Colin B Boswell Dds PC	NH	Pediatric Dentistry	$0	$5.2M
Golden Cross Ambulance Inc	NH	Ambulance	$1.2M	$3.5M
Claremont School District	NH	Local Education Agency (LEA)	$0	$3M
Sullivan County Oral Health Collaborative	NH	Dental Clinic/Center	$0	$892.1K
Valley Regional Hospital, Inc.	NH	Urgent Care Clinic/Center	$0	$875.8K
Valley Regional Hospital, Inc	NH	Family Medicine Physician	$0	$782K
Samuel Giveen	NH	Optometrist	$120.2K	$544.2K
Tlc Family Resource Center	NH	Public Health or Welfare Agency	$0	$611.6K

Daniel Peraza — Billing Profile & Reimbursement Data

Sign up for Daniel Peraza — Billing Profile & Reimbursement Data policy alerts

Daniel Peraza — Billing Profile & Reimbursement Data

Sign up for Daniel Peraza — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References